skip to main content
Resultados 1 2 3 4 5 next page
Mostrar solo
Result Number Material Type Add to My Shelf Action Record Details and Options
1
SA 9.1 Optimal neoadjuvant and adjuvant therapy for patients with early triple negative breast cancer
Material Type:
Artículo
Añadir a Mi Portal

SA 9.1 Optimal neoadjuvant and adjuvant therapy for patients with early triple negative breast cancer

Rugo, H.S.

Breast (Edinburgh), 2023-04, Vol.68, p.S10-S10 [Revista revisada por pares]

Elsevier Ltd

Texto completo disponible

2
Pembrolizumab monotherapy for previously treated metastatic triple-negative breast cancer: cohort A of the phase II KEYNOTE-086 study
Material Type:
Artículo
Añadir a Mi Portal

Pembrolizumab monotherapy for previously treated metastatic triple-negative breast cancer: cohort A of the phase II KEYNOTE-086 study

Adams, S. ; Schmid, P. ; Rugo, H.S. ; Winer, E.P. ; Loirat, D. ; Awada, A. ; Cescon, D.W. ; Iwata, H. ; Campone, M. ; Nanda, R. ; Hui, R. ; Curigliano, G. ; Toppmeyer, D. ; O’Shaughnessy, J. ; Loi, S. ; Paluch-Shimon, S. ; Tan, A.R. ; Card, D. ; Zhao, J. ; Karantza, V. ; Cortés, J.

Annals of oncology, 2019-03, Vol.30 (3), p.397-404 [Revista revisada por pares]

England: Elsevier Ltd

Texto completo disponible

3
Alpelisib plus fulvestrant for PIK3CA-mutated, hormone receptor-positive, human epidermal growth factor receptor-2–negative advanced breast cancer: final overall survival results from SOLAR-1
Material Type:
Artículo
Añadir a Mi Portal

Alpelisib plus fulvestrant for PIK3CA-mutated, hormone receptor-positive, human epidermal growth factor receptor-2–negative advanced breast cancer: final overall survival results from SOLAR-1

André, F. ; Ciruelos, E.M. ; Juric, D. ; Loibl, S. ; Campone, M. ; Mayer, I.A. ; Rubovszky, G. ; Yamashita, T. ; Kaufman, B. ; Lu, Y.-S. ; Inoue, K. ; Pápai, Z. ; Takahashi, M. ; Ghaznawi, F. ; Mills, D. ; Kaper, M. ; Miller, M. ; Conte, P.F. ; Iwata, H. ; Rugo, H.S.

Annals of oncology, 2021-02, Vol.32 (2), p.208-217 [Revista revisada por pares]

England: Elsevier Ltd

Texto completo disponible

4
Pembrolizumab monotherapy for previously untreated, PD-L1-positive, metastatic triple-negative breast cancer: cohort B of the phase II KEYNOTE-086 study
Material Type:
Artículo
Añadir a Mi Portal

Pembrolizumab monotherapy for previously untreated, PD-L1-positive, metastatic triple-negative breast cancer: cohort B of the phase II KEYNOTE-086 study

Adams, S. ; Loi, S. ; Toppmeyer, D. ; Cescon, D.W. ; De Laurentiis, M. ; Nanda, R. ; Winer, E.P. ; Mukai, H. ; Tamura, K. ; Armstrong, A. ; Liu, M.C. ; Iwata, H. ; Ryvo, L. ; Wimberger, P. ; Rugo, H.S. ; Tan, A.R. ; Jia, L. ; Ding, Y. ; Karantza, V. ; Schmid, P.

Annals of oncology, 2019-03, Vol.30 (3), p.405-411 [Revista revisada por pares]

England: Elsevier Ltd

Texto completo disponible

5
4th ESO-ESMO International Consensus Guidelines for Advanced Breast Cancer (ABC 4)
Material Type:
Artículo
Añadir a Mi Portal

4th ESO-ESMO International Consensus Guidelines for Advanced Breast Cancer (ABC 4)

Cardoso, F ; Senkus, E ; Costa, A ; Papadopoulos, E ; Aapro, M ; André, F ; Harbeck, N ; Aguilar Lopez, B ; Barrios, C H ; Bergh, J ; Biganzoli, L ; Boers-Doets, C B ; Cardoso, M J ; Carey, L A ; Cortés, J ; Curigliano, G ; Diéras, V ; El Saghir, N S ; Eniu, A ; Fallowfield, L ; Francis, P A ; Gelmon, K ; Johnston, S R D ; Kaufman, B ; Koppikar, S ; Krop, I E ; Mayer, M ; Nakigudde, G ; Offersen, B V ; Ohno, S ; Pagani, O ; Paluch-Shimon, S ; Penault-Llorca, F ; Prat, A ; Rugo, H S ; Sledge, G W ; Spence, D ; Thomssen, C ; Vorobiof, D A ; Xu, B ; Norton, L ; Winer, E P

Annals of oncology, 2018-08, Vol.29 (8), p.1634-1657 [Revista revisada por pares]

England: Oxford University Press

Texto completo disponible

6
Impact of palbociclib plus letrozole on patient-reported health-related quality of life: results from the PALOMA-2 trial
Material Type:
Artículo
Añadir a Mi Portal

Impact of palbociclib plus letrozole on patient-reported health-related quality of life: results from the PALOMA-2 trial

Rugo, H.S. ; Diéras, V. ; Gelmon, K.A. ; Finn, R.S. ; Slamon, D.J. ; Martin, M. ; Neven, P. ; Shparyk, Y. ; Mori, A. ; Lu, D.R. ; Bhattacharyya, H. ; Bartlett, C.H.u.a.n.g. ; Iyer, S. ; Johnston, S. ; Ettl, J. ; Harbeck, N.

Annals of oncology, 2018-04, Vol.29 (4), p.888-894 [Revista revisada por pares]

England: Elsevier Ltd

Texto completo disponible

7
The breast cancer continuum in hormone-receptor–positive breast cancer in postmenopausal women: evolving management options focusing on aromatase inhibitors
Material Type:
Artículo
Añadir a Mi Portal

The breast cancer continuum in hormone-receptor–positive breast cancer in postmenopausal women: evolving management options focusing on aromatase inhibitors

Rugo, H. S

Annals of oncology, 2008-01, Vol.19 (1), p.16-27 [Revista revisada por pares]

Oxford: Oxford University Press

Texto completo disponible

8
Alpelisib (ALP) + fulvestrant (FUL) for advanced breast cancer (ABC): Results of the phase III SOLAR-1 trial
Material Type:
Artículo
Añadir a Mi Portal

Alpelisib (ALP) + fulvestrant (FUL) for advanced breast cancer (ABC): Results of the phase III SOLAR-1 trial

André, F. ; Ciruelos, E.M. ; Rubovszky, G. ; Campone, M. ; Loibl, S. ; Rugo, H.S. ; Iwata, H. ; Conte, P. ; Mayer, I.A. ; Kaufman, B. ; Yamashita, T. ; Lu, Y.-S. ; Inoue, K. ; Takahashi, M. ; Pápai, Z. ; Longin, A.-S. ; Mills, D. ; Wilke, C. ; Hirawat, S. ; Juric, D.

Annals of oncology, 2018-10, Vol.29, p.viii709-viii709 [Revista revisada por pares]

England: Elsevier Ltd

Texto completo disponible

9
A phase Ib study of pexidartinib (PLX3397) and weekly paclitaxel in patients with advanced solid tumors including an ovarian cancer subset
Material Type:
Artículo
Añadir a Mi Portal

A phase Ib study of pexidartinib (PLX3397) and weekly paclitaxel in patients with advanced solid tumors including an ovarian cancer subset

Wesolowski, R ; Sharma, N ; West, B ; Coussens, L ; Marimuthu, A ; Pelayo, M ; Le, M.H ; Hsu, H ; Karlin, D.A ; Rugo, H.S

Gynecologic oncology, 2016-06, Vol.141, p.121-121 [Revista revisada por pares]

Elsevier Inc

Texto completo disponible

10
Relationship between tumor infiltrating lymphocyte (TIL) levels and response to pembrolizumab (pembro) in metastatic triple-negative breast cancer (mTNBC): Results from KEYNOTE-086
Material Type:
Artículo
Añadir a Mi Portal

Relationship between tumor infiltrating lymphocyte (TIL) levels and response to pembrolizumab (pembro) in metastatic triple-negative breast cancer (mTNBC): Results from KEYNOTE-086

Loi, S. ; Adams, S. ; Schmid, P. ; Cortés, J. ; Cescon, D.W. ; Winer, E.P. ; Toppmeyer, D.L. ; Rugo, H.S. ; De Laurentiis, M. ; Nanda, R. ; Iwata, H. ; Awada, A. ; Tan, A. ; Wang, A. ; Aktan, G. ; Karantza, V. ; Salgado, R.

Annals of oncology, 2017-09, Vol.28, p.v608-v608 [Revista revisada por pares]

Elsevier Ltd

Texto completo disponible

Resultados 1 2 3 4 5 next page

Personalizar los resultados

  1. Editar

Refine Search Results

Ampliar mis resultados

  1.   

Mostrar solo

  1. Revistas arbitradas (165)

Fecha de Publicación 

De Hasta
  1. Antes de2008  (4)
  2. 2008Hasta2011  (4)
  3. 2012Hasta2016  (16)
  4. 2017Hasta2020  (73)
  5. Después de 2020  (73)
  6. Más opciones open sub menu

Buscando en bases de datos remotas, por favor espere

  • Buscando por
  • enscope:(USP_VIDEOS),scope:("PRIMO"),scope:(USP_FISICO),scope:(USP_EREVISTAS),scope:(USP),scope:(USP_EBOOKS),scope:(USP_PRODUCAO),primo_central_multiple_fe
  • Mostrar lo que tiene hasta ahora